# Antagonist/Letrozole in Poor Responders

> **NCT00823004** · PHASE1,PHASE2 · COMPLETED · sponsor: **Yazd Research & Clinical Center for Infertility** · enrollment: 120 (actual)

## Conditions studied

- Ovarian Stimulation

## Interventions

- **DRUG:** letrozole
- **DRUG:** oral contraceptive (Marvelone)
- **DRUG:** GnRH agonist (buserelin)
- **DRUG:** recombinant FSH or hMG
- **DRUG:** ganirelix acetate

## Key facts

- **NCT ID:** NCT00823004
- **Lead sponsor:** Yazd Research & Clinical Center for Infertility
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2009-02
- **Final completion:** 2009-10
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2013-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00823004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00823004, "Antagonist/Letrozole in Poor Responders". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00823004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*